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Introduction
The herpes simplex virus (HSV) amplicon system represents one type of viral vector that is able to infect neurons and other post-mitotic cells. This system consists of a mixture of amplicon vectors that contain a gene of interest and from HSV-1 cis signals necessary for replication and packaging, as well as helper viruses that provide the essential trans functions of viral replication. Gene therapy is used to alter neuronal physiology and to intervene in the pathological cascade of events that is induced in neurons following various insults. Many steps in the necrotic death pathway have been targeted successfully with viral vectors (derived from HSV or adenovirus) including energetic components (by overexpressing a glucose transporter), [1] [2] [3] [4] the calcium excess (with overexpression of the calcium binding protein, calbindin D 28k ), [5] [6] [7] the protein malfolding (with hsp72), 8, 9 the apoptotic elements (with apoptosis inhibitors such as bcl-2 or NAIP), [10] [11] [12] [13] [14] and the inflammatory elements. 15, 16 In contrast to these consistent findings, results concern- ing the effects of viral infection itself (independent of the gene delivered) are not clear. Some early reports showed HSV mutants with the ␣4 immediate-early gene deletion to be relatively innocuous. [17] [18] [19] Likewise, stereotactic delivery of HSV vectors in vivo did not appear to cause gross anatomical or behavioral changes. 17, 20 Later work indicated that these vectors caused significant damage in E5 cells and in cultured neurons. 21, 22 Following more rigorous histological assessment, ventricular enlargement, vascular inflammation, infiltration by astrocytes and microglia, and tissue necrosis at primary injection sites were documented. [23] [24] [25] These contrasting anatomical findings suggest that a functional analysis may be more informative with regard to the invasiveness of gene therapy.
Most gene therapy experiments determine the efficacy of a neuroprotective vector by comparing its actions with a control vector (eg one expressing a reporter gene, or one containing the transgene under study interrupted by a stop codon). Therefore, these studies do not address the effects of vector delivery, per se. Some experiments use a tripartite method by including an additional group that receives vehicle alone. Most of these experiments revealed no difference between control vector or vehicle on various measures including enzyme production, ion channel currents and transmitter release. 12, [26] [27] [28] [29] [30] In con-trast, others reported alterations in calcium regulation or metabolism following an insult with delivery of a control vector. 2, 6, 11 Since infection itself may affect only some aspects of neuronal function, clinical relevance may be better understood by examining more inclusive measures.
The objective of this study was to investigate the effects of HSV vectors on hippocampal synaptic transmission in vivo. We chose to measure population synaptic responses to provide an overall assessment of the ability of neurons to manage multiple aspects of cellular function. We recorded electrically evoked field excitatory post-synaptic potentials (EPSPs) in animals that received either vector or phosphate-buffered saline (PBS). Data from this study address questions concerning the use of viruses in the CNS and the status of brain function following gene therapy. The current results provide some insight into the functional ramifications of vector delivery by showing that population synaptic transmission in the hippocampus, is not altered by HSV infection. Figure 1a shows averaged EPSP waveforms recorded at low and high stimulation intensities from individual animals receiving lac-Z or PBS. The mean EPSP slope was calculated at each stimulus level of input/output (I/O) curves taken from lac-Z and PBS animals. Similar I/O curves were obtained in animals that received control vector or PBS suggesting no effect of the vector on PP-DG synaptic strength (Figure 1b ). There was no difference in the mean y-intercept between groups (lac-Z: 44.89 ± 13.03 A, PBS: 31.44 ± 10.81 A) suggesting no difference in EPSP threshold.
Results

PP-DG electrophysiology
To determine if our recording system could detect physiological changes due to infection, we delivered an HSV vector containing the gene for the calcium-binding protein, calbindin D 28k , to a subset of animals. Expression of this protein has been shown to alter synaptic transmission in cultured hippocampal neurons. 31 Thus, we used calbindin D 28k as a positive control. Figure 1b contains the I/O curve for mean EPSP slope in calbindin D 28k -treated animals. I/O curves recorded in animals that received calbindin D 28k were larger than those observed in the control vector or PBS group. This potentiation was most readily observed at lower stimulation intensities. At the lowest three levels above threshold (50, 100, 150 A), EPSP slope means from calbindin D 28k -treated animals were over 200% of those recorded in animals that received lac-Z vector or PBS. Taken together, these data demonstrate that the experimental design was able to resolve differences in synaptic function due to vector delivery, thus, implying that the lack of differences in the preceding data was due to an absence of an effect of lac-Z relative to PBS and not to resolution difficulties.
To examine possible effects on short-term synaptic plasticity, paired stimulation pulses were delivered at each level of the I/O curve and mean per cent PPF was calculated for each group at each level. The response to the test pulse was facilitated at lower and depressed at higher stimulus levels relative to the response to the conditioning pulse in both groups (Figure 1c) . No difference in per cent PPF was observed between lac-Z or PBS animals suggesting no effect of vector delivery on short-term plasticity at PP-DG synapses.
MF-CA3 electrophysiology
In separate groups of animals that received lac-Z or PBS, we measured evoked MF-CA3 synaptic responses ( Figure  2a ). Figure 2b shows averaged EPSP slope values at each level of the I/O curve for lac-Z or PBS animals. The evoked EPSP increased with increasing stimulation intensity in a similar fashion for both groups. In addition, there was no difference in the mean y-intercept between groups (lac-Z: 56.01 ± 14.96 A, PBS: 36.09 ± 33.44 A) suggesting no difference in MF-CA3 EPSP threshold.
As was performed for PP-DG responses, PPF was calculated for MF-CA3 EPSPs for each group at each level of the I/O curve. As shown in Figure 2c , the response to the test pulse was facilitated at lower and depressed at higher stimulus levels relative to the response to the conditioning pulse. No group differences in per cent PPF were observed suggesting no alteration in short-term plasticity at MF-CA3 synapses due to infection. 
Figure 2 MF-CA3 EPSPs recorded 72 h after delivery of lac-Z or PBS. (a) Averaged waveforms (five sweeps) of EPSPs recorded at low (250 A) and high stimulation intensities (600 A) in animals receiving lac-Z (n = 8) or PBS (n = 10). (b) Mean EPSP slope value for each stimulation intensity of the I/O curve for lac-Z (filled circles) and PBS groups (open circles). A two-way
Expression
Hippocampal neurons that stained positive for X-gal in sections from animals that received lac-Z or calbindin D 28k were counted under low-power light microscopy ( Figure 3 ). Infected neurons were observed predominantly in the granule cell layers of the DG. In various animals, X-gal-positive cells were seen in areas of Ammon's Horn (CA1-CA4). The total number of infected cells was counted in the two sections that best showed the recording electrode tract and all sections with expression were analyzed to determine the extent of A/P diffusion. There was no difference in the number of Xgal-positive cells at the recording electrode or A/P diffusion when comparing lac-Z vector with calbindin D 28k vector (data not shown) making it unlikely that physiological differences between groups were due to differences in the amount of infection.
Discussion
The results from this study show that infection of granule cells with HSV vectors in vivo does not alter excitatory synaptic transmission to or from the DG. We observed no effect on synaptic strength at PP-DG or MF-CA3 population synaptic strength as indicated by no difference in I/O curves for EPSPs recorded 72 h after injection of lac-Z or PBS. Although the exact number of neurons or synapses that contribute to the population EPSP is not known (roughly on the order of thousands of neurons or
Figure 3 Panels show expression patterns in representative animals that received lac-Z or calbindin D 28k delivered to the DG. (a) Coronal section showing the recording electrode tract (arrow) and expression in an animal that received lac-Z. (b) Coronal section taken near the recording electrode from an animal that received calbindin D 28k . (c) Examples of substantial expression in Ammon's Horn in a lac-Z animal. Sections in (A) and (B)
show expression at roughly 1 mm anterior to the injection site. All photos were taken at 40 × magnification.
tens of thousands of synapses), expression was noted in sections that contained the recording (PP-DG recording) or stimulating electrode (MF-CA3 recording). Since the number of infected neurons involved in the physiological response could not be measured in this assay, we examined the effect of a positive control vector that showed similar levels of expression, calbindin D 28k . Delivery of the calbindin D 28k gene to DG granule cells resulted in potentiation of PP-DG synaptic strength. The functional changes observed following delivery of calbindin D 28k suggest that the electrophysiological results reflect, at least in part, synaptic function in infected neurons. The current findings provide evidence that neurons infected with HSV vectors remain able to carry out their normal communication functions with other neurons.
In addition to DG granule cells, we observed expression in other areas of the hippocampus. The results show X-gal-positive pyramidal neurons in all areas of Ammon's Horn ( Figure 3C ). Before this investigation, experiments showed HSV infection in primary injection sites in various brain areas including the caudate putamen, the cortex and the hippocampus. 2, 17, 23, 25 Most of these studies revealed residual expression in secondary sites as well postulating diffusion of the vector, retrograde transport or tropism. 2, 17, 23 In a previous experiment from our laboratory geared toward gene therapy with HSV amplicons in the hippocampus, we observed reporter gene expression almost exclusively in DG granule cells even when the amplicon was injected in area CA3 or CA4. 2 One explanation for the contrasting findings is that expression patterns are different in the presence or absence of damage since most experiments previously carried out in vivo involved a concurrent insult. However, interhemispheric differences in X-gal staining were not reported for animals that received unilateral insult. 12 The data also argue against the idea that infection is targeted by membrane proteoglycans found predominantly on DG granule cells 2 or that infection occurs only in neurons that are not postmitotic (unlike the vast majority of neurons in the brain, DG granule cells regenerate themselves at low levels throughout the life span). 32 Regardless, the current data indicate that the use of HSV virus systems for gene therapy in the hippocampus may not be limited to the dentate gyrus.
As stated above, tissue necrosis and signs of immune activation have been observed following in vivo delivery of HSV vectors. [23] [24] [25] In addition to the anatomical data, experiments using mock-as well as control-infected neuronal cultures showed that control vectors can reduce free cytosolic calcium accumulation 6 and reduce metabolism in response to hypoglycemia (both measured at 24 h after the insult). 2 Functional consequences of viral infection could be due to direct effects of the virion on cell metabolism and DNA transcription [33] [34] [35] or to secondary effects mediated by immune messengers and cytokines. Immune activity stimulated by HSV infection in the central nervous system has been observed [36] [37] [38] and many immune messengers have the ability to affect hippocampal physiology. [39] [40] [41] [42] [43] [44] [45] While measures of immune activity were not taken, the current data support the idea that vector delivery does not stimulate an immune response sufficient to alter hippocampal synaptic physiology.
Viral vectors have proved to be powerful tools to intervene in the neuron death that occurs following acute insults in vitro and in vivo. Behavioral analyses have shown that vector delivery post-insult can have sparing effects on the functional level as well. 26, 46, 47 In light of these results, it would be interesting to see if these vectors also spare synaptic function and plasticity in relevant brain regions. This study supports the use of HSV viral vectors to deliver genes to the central nervous system to alter physiology and possibly spare neuron function following an insult.
Materials and methods
Vector construction/delivery Viruses were constructed in our laboratory using methods described in Ho. 48 First, E5 cells were transfected with p␣4s␤gal (an amplicon plasmid which carries the lacZ gene under the control of the HSV ␣4 promoter alone), or with p␣4CBp␣22␤gal (a bicistronic plasmid which carries the lacZ and the calbindin D 28k genes). These cells were then superinfected with a d120 helper virus. 49 After maximum infection, the viruses were released by sonication, partially purified using high speed centrifugation (overlayed on 30% sucrose, 21K r.p.m. for 19 h at 4°C), resuspended in PBS and frozen (−70°C) for later use. Animals that received the p␣4s␤gal plasmid are referred to as lac-Z animals. Those that received the p␣4CBp␣22␤gal plasmid are referred to as calbindin D 28k animals.
Male Sprague-Dawley albino rats (270-480 g, Simonsen, Gilroy, CA, USA; Charles River, Charleston, MA, USA) were maintained on a 12:12 light:dark cycle (lights on at 8 am) for at least 1 week after arrival in our animal colony and allowed food and water ad libitum. Experiments were conducted during the light phase. Animals were injected with Nembutal (Abbott, Chicago, IL, USA) (65 mg/kg) before surgery and anesthesia levels were maintained with subsequent injections (approximately 15 mg/kg) roughly every 40 min. A guide cannula was lowered into the DG (−4.8 A/P, ±3.0 M/L relative to bregma, −3.2-3.4 D/V from dura). lac-Z (amplicon/helper: 2.4 × 10 7 /6.7 × 10 7 particles/ml), calbindin D 28k (4.5 × 10 6 /3.8 × 10 7 particles/ml), or PBS was injected (2 l, 0.5 L/min) through an injection cannula extending approximately 0.5 mm beyond the guide. Rate was controlled using a microinfusion pump (Harvard Apparatus, Holliston, MA, USA) and injection cannulae were left in place for at least 2 min following injection. In most instances, subsequent electrophysiology was performed blind with respect to the substance injected.
Electrophysiology
Experiments were designed to test transmission at PP-DG and MF-CA3 synapses. Seventy-two hours after injection, animals were anesthetized and a recording electrode was advanced into the hippocampus (teflon-insulated stainless steel, mm from bregma: −3. 
I/O curves
A total of 10 responses was recorded at each of eight predetermined stimulation intensities (in A: 25, 50, 100, 150, 250, 400, 600, 900). Five responses were recorded at each level as the stimulation intensity was increased and five more were taken as the stimulation was decreased (0.1 Hz stimulation rate). The maximum slope across 1 ms of the initial ascending phase of the conditioning EPSP slope was extracted to determine changes in synaptic strength. This parameter of the field response is considered to be the least contaminated measure of the excitatory synaptic potential.
When two stimulation pulses of equal intensity are delivered in rapid succession, the synaptic response to the second pulse is facilitated relative to the first response. PPF is a form of short-term synaptic plasticity and is believed to be due to residual calcium in the presynaptic terminal resulting in an increase in transmitter release. 50 Analysis of PPF was used as an additional measure of synaptic function and as a control for the possibility of offsetting pre-and post-synaptic changes. To calculate PPF, the EPSP slope value for each test (second) response was divided by its corresponding conditioning (first) EPSP slope value and multiplied by 100 to produce a per cent PPF measure. Conditioning EPSP slope values and per cent PPF values were averaged at each level of the I/O curve. The four levels of individual PP-DG I/O curves that constituted the most linear portion of the curve were used to calculate regression lines (y = stimulation intensity, x = mean EPSP slope) to determine the y-intercept, an estimate of EPSP threshold.
Histology Animals were perfused with heparinized saline followed by 3% paraformaldehyde in PBS immediately following the last recording period for each experiment. Brains were removed and placed in 30% sucrose in paraformaldehyde for 24-72 h. Every third coronal section (30 m) was slide mounted and incubated in X-gal solution (Molecular Probes, Eugene, OR, USA) for 16-24 h. Positive (blue) cells were counted under low-power light microscopy (40 or 100 ×).
Statistics Two-way ANOVAs (group × stimulation intensity) were performed to assess group differences in mean EPSP slope and PPF across the I/O curve. Unpaired t tests were used to compare all other electrophysiological parameters and cell counts. Error terms are standard error of the mean.
